Hung Do
Geen lopende functies
Profiel
Hung Do richtte Callidus Biopharma, Inc. op. Dr. Do is Chief Science Officer bij Amicus Therapeutics, Inc. Daarvoor was hij Director & Chief Scientific Officer bij Callidus Biopharma, Inc., Project Leader bij Genzyme Corp. en Principal bij Novazyme Pharmaceuticals, Inc. Hung Do behaalde een doctoraat aan de Texas A&M University.
Eerdere bekende functies van Hung Do
Bedrijven | Functie | Einde |
---|---|---|
Callidus Biopharma, Inc.
Callidus Biopharma, Inc. BiotechnologyHealth Technology Callidus Biopharma, Inc. develops drug discovery services. The firm focuses on enzyme replacement therapies (ERTs) for lysosomal storage disorders (LSDs). Its novel technology platform is based on attaching a form of the naturally occurring Insulin-like growth factor (IGF-2) to enhance the targeting of therapeutic enzymes to the relevant cells in the body. The company was founded by Cuong Viet Do and Hung Do in 2010 and is headquartered in Bensalem, PA. | Founder | 01-11-2013 |
AMICUS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Novazyme Pharmaceuticals, Inc.
Novazyme Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Novazyme Pharmaceuticals, Inc. researches and develops methods for modifying recombinantly produced enzymes. It develops a series of novel protein engineering technologies that have been shown in pre-clinical studies to greatly enhance the targeting and uptake of replacement enzymes. Novazyme's technologies also have application for developing advanced monoclonal antibodies and gene therapies. The company is located in Oklahoma City, OK. | Corporate Officer/Principal | - |
Opleiding van Hung Do
Texas A&M University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
AMICUS THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Callidus Biopharma, Inc.
Callidus Biopharma, Inc. BiotechnologyHealth Technology Callidus Biopharma, Inc. develops drug discovery services. The firm focuses on enzyme replacement therapies (ERTs) for lysosomal storage disorders (LSDs). Its novel technology platform is based on attaching a form of the naturally occurring Insulin-like growth factor (IGF-2) to enhance the targeting of therapeutic enzymes to the relevant cells in the body. The company was founded by Cuong Viet Do and Hung Do in 2010 and is headquartered in Bensalem, PA. | Health Technology |
Novazyme Pharmaceuticals, Inc.
Novazyme Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Novazyme Pharmaceuticals, Inc. researches and develops methods for modifying recombinantly produced enzymes. It develops a series of novel protein engineering technologies that have been shown in pre-clinical studies to greatly enhance the targeting and uptake of replacement enzymes. Novazyme's technologies also have application for developing advanced monoclonal antibodies and gene therapies. The company is located in Oklahoma City, OK. | Commercial Services |